ArticleClinical and experimental medicine2019

Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.

Ruyu Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.